Sign In

Molly Gasperini

Associate Director, Genome Engineering

Professional Background

Molly Gasperini is a highly accomplished scientist specializing in molecular genetics and genomics. Currently, she serves as an Assistant Investigator in the Molecular Genetics group at the Allen Institute for Brain Science, renowned for its pioneering research in the understanding of the brain. In this significant role, she leads a dedicated team focused on gene regulation and genomics, contributing innovative insights and advancements in these critical areas of study.

Before her current position at the Allen Institute, Molly made substantial contributions as the Senior Scientist and Team Lead at Cajal Neuro, a company dedicated to the discovery of therapeutic targets for neurodegenerative diseases such as Parkinson's and Alzheimer's. Under her leadership, the team successfully implemented novel in vitro neuronal CRISPR screens, showcasing her expertise in cutting-edge genetic manipulation techniques and her commitment to advancing neurobiology research.

Molly’s journey in the scientific field began with her role as an early scientist at Octant Bio, a dynamic drug discovery startup. Her experience there further solidified her scientific acumen and equipped her with valuable insights into the drug development process. With a solid foundation in molecular biology, she has been instrumental in the rapidly evolving domain of genomics and gene regulation.

Her early career laid the groundwork for her future accomplishments; she honed her skills as a Research Assistant in renowned labs, including those led by Mary Claire King at the University of Washington and Lou Kunkel at Harvard Medical School. Here, she established her expertise in human genetics, which would prove essential throughout her career.

Education and Achievements

Molly earned her Doctor of Philosophy (PhD) in Genome Sciences from the prestigious University of Washington. During her graduate studies, she was a trailblazer in the development of CRISPR genome engineering and single-cell RNA sequencing (scRNAseq), effectively testing thousands of genetic elements in various experimental conditions. This innovative approach has been vital in pushing the boundaries of genetic research and applications.

Her educational journey began with a Bachelor of Science (B.S.) in Molecular Biology with a focus on Human Genetics, also from the University of Washington. This robust academic background laid the foundation for her impressive career trajectory in the biological sciences. Molly’s time in the academic environment instilled a deep passion for understanding complex genetic interactions and mechanisms, further motivating her to pursue research that has far-reaching implications.

Additionally, Molly has served in various capacities that showcase her leadership and mentorship abilities. She was previously the Associate Director of Genome Engineering at Seahub at the Allen Institute, where she played a pivotal role in overseeing genomic engineering projects, further leading advancements in the science of genetic manipulation.

Throughout her career, she has actively contributed to scientific communities and organizations, such as serving as a Scientific Consultant at Variant Bio and holding a position on the Programming Committee at ComSciCon, which focuses on empowering the next generation of science communicators. Her volunteer work as a mentor at the Science Club for Girls highlights her commitment to nurturing future scientists and promoting diversity in the field of science.

Achievements

Molly Gasperini's journey in the realm of molecular genetics is marked by numerous noteworthy achievements and contributions. Her pioneering work in CRISPR gene editing and her role in developing innovative experimental designs have earned her respect and recognition within the scientific community. As a thought leader in her field, she continues to explore uncharted territories in genetic research, aimed at unlocking the mysteries of human health and disease.

Her involvement in high-impact projects and companies signifies her dedication to advancing our understanding of the brain and its associated genetic factors. Through her ongoing research, she contributes valuable knowledge that could lead to the identification of novel therapeutic targets, enhancing our understanding of neurodegenerative diseases that affect millions globally.

Molly Gasperini is actively engaged in shaping the future of molecular genetics, emphasizing gene regulation, pharmacogenomics, and genetic screening technologies. Her insights and efforts are paving the way for groundbreaking discoveries that can improve health outcomes and influence how we understand and address complex genetic disorders.

Achievements

Molly Gasperini has received numerous accolades for her work in genetic research, contributing important insights into human genetics and molecular biology.

Educational Background

PhD in Genome Sciences from the University of Washington; Bachelor of Science in Molecular Biology from the University of Washington.

Related Questions

How did Molly Gasperini innovate CRISPR genome engineering during her PhD studies at the University of Washington?
What leadership strategies did Molly Gasperini implement while overseeing her team at Cajal Neuro?
In what ways has Molly Gasperini contributed to the understanding of neurodegenerative diseases through her research?
What is Molly Gasperini's impact on the development of in vitro neuronal CRISPR screens in neuroscience?
How has Molly Gasperini's educational background shaped her career trajectory in genetic research?
Molly Gasperini
Add to my network

Location

Seattle, Washington, United States